Cargando…
Elevated serum Neurofilament Light chain (NfL) as a potential biomarker of neurological involvement in Myotonic Dystrophy type 1 (DM1)
BACKGROUND: Cognitive and behavioural symptoms due to involvement of the central nervous system (CNS) are among the main clinical manifestations of Myotonic Dystrophy type 1 (DM1). Such symptoms affect patients’ quality of life and disease awareness, impacting on disease prognosis by reducing compli...
Autores principales: | Nicoletti, Tommaso F., Rossi, Salvatore, Vita, Maria Gabriella, Perna, Alessia, Guerrera, Gisella, Lino, Federica, Iacovelli, Chiara, Di Natale, Daniele, Modoni, Anna, Battistini, Luca, Silvestri, Gabriella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363395/ https://www.ncbi.nlm.nih.gov/pubmed/35575811 http://dx.doi.org/10.1007/s00415-022-11165-0 |
Ejemplares similares
-
Fluid Biomarkers of Central Nervous System (CNS) Involvement in Myotonic Dystrophy Type 1 (DM1)
por: Rossi, Salvatore, et al.
Publicado: (2023) -
Resveratrol corrects aberrant splicing of RYR1 pre-mRNA and Ca(2+) signal in myotonic dystrophy type 1 myotubes
por: Santoro, Massimo, et al.
Publicado: (2020) -
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials
por: Garibaldi, Matteo, et al.
Publicado: (2021) -
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study
por: Perna, Alessia, et al.
Publicado: (2020) -
Editorial: Myotonic Dystrophies: Developments in Research From Bench to Bedside
por: Silvestri, Gabriella, et al.
Publicado: (2020)